Free On-line Access

SPCI - Sociedade Portuguesa de Cuidados Intensivos

Revista Brasileira de Terapia Intensiva

AMIB - Associação de Medicina Intensiva Brasileira


ISSN: 0103-507X
Online ISSN: 1982-4335

Instructions for Authors

Revista Brasileira de Terapia Intensiva/Brazilian Journal of Intensive Care (RBTI/BJIC), ISSN 0103-507X, is the scientific journal of the Associação de Medicina Intensiva Brasileira (AMIB) and Sociedade Portuguesa de Cuidados Intensivos quarterly issued scientific journal. It aims to publish relevant research involving acutely ill patients health care improvement, providing discussion, distribution and promotion of evidence-based information to intensive care professionals. It publishes research, review, comments, case report articles and letters to the Editor, involving all areas of knowledge related to intensive care of the critically ill patient.

RBTI endorses the recommendations from International Committee of Medical Journal Editors - Uniform Requirements for Manuscripts Submitted to Biomedical Journals, updated in April 2010, available in

All content of Revista Brasileira de Terapia Intensiva/Brazilian Journal of Intensive Care is licensed under a Creative Commons (CCBY) Attribution 4.0 International License (

The on-line jornal has open and free access.

Submission process
The manuscripts can be submitted either in English, Portuguese or Spanish. RBTI is published in a Portuguese printed version and a Portuguese and English electronic version. No fee for evaluation or publication of the manuscripts will be charged to the authors. The journal will translate the articles submitted in Portuguese (or Spanish) and the translation costs will be covered by the journal. Articles submitted in English will be translated by the journal into Portuguese, with no expenses to the authors. All articles must be electronically submitted at:

Authors should submit to the Journal:
Cover letter - It should contain a declaration stating that the article is original, has not been or is not being submitted for publication in another journal. Authors should also state that the study was approved by the Research Ethics Committee (REC) of the institution where the study was conducted (or a reference REC), mentioning the number of registration and, if appropriate, a statement that informed consent was obtained or exempted by the REC. If required, during the peer review process, authors might be asked to send a copy of REC approval.

Declaration of Conflict of Interest - Authors should download the appropriate form, (please download here) and, after signature of the authors, upload it during the submission process. This declaration, according to resolution of the Federal Medical Council No. 1595/2000, prohibits scientific paper to promote or advertise any commercial products or equipment.
Funding - Information of possible sources of funding for research will be required during the submission process as well as in the title page of the manuscript.
Copyright transfer and publication authorization- After acceptance, a authorization signed by all authors to publish and a copyright transfer to the journal should be sent to Journal office (please download here).
Patient's information - For all manuscripts that include information or clinical photographs in which patients can be individually identified, a writing consent signed by each patient or his family should be sent.

Peer review process
All manuscripts submitted to RBTI are subject to rigorous review. The initial submissions are reviewed by internal staff to ensure adherence to RBTI policies, including ethical requirements for human and animal experimentation. After this initial evaluation, the article can be send back to the authors for adequacy.
Afterwards, the submitted manuscripts will be evaluated checked by the Editor. Manuscripts without merit, bearing significant methodology errors, or not fitting the journals editorial policy will be rejected, without a formal peer review process. Our average turn-around time for this immediate rejection is one week.
After the Editor-in-chiefs (or a designated editor) approval, the articles will be forwarded to two or more reviewers. They will always be from institutions different from the one the manuscript is from, being the anonymous condition kept during the entire editorial process. Our average turn-around time for the first answer to the authors is 30 days although a longer time might be required. After evaluation, the editors will choose between the following decisions: accept, minor revision, major revision, rejected and resubmit or reject. RBTI's acceptance rate is approximately 30%. In the past 12 months, the median time from submission to first decision for all articles was 28 days.


After receiving the reviewers opinion, the authors should submit the revised version within 60 days including the suggested changes together with a point-to-point answer to each reviewer. Authors may contact RBTI ([email protected]) if they require an extension. If not submitted within 6 months, the manuscript will be removed from the data base and an eventual resubmission will follow the initial submissions track. Upon resubmission, the editors may choose to send the manuscript back to external reviewers, or may render a decision based on personal expertise.
The opinions expressed in the articles, including reviewer-requested changes, will be the only authors responsibility.

When reporting experiments on human subjects, authors should indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national, if applicable) and with the Helsinki Declaration of 1975, as revised in 2000. When reporting experiments on animals, authors should be asked to indicate whether the institutional and national guide for the care and use of laboratory animals was followed. In any either clinical or experimental, human or animal studies these information should be placed in the section Methods.
Revista Brasileira de Terapia Intensiva ethical statements can be found in our website

Anti-plagiarism policy

Any contribution submitted to RBTI must be original and the manuscript, or parts of it, must not be under consideration by any other journal. Also, authors should not submit the same manuscript in different languages to different journals. Authors should declare any potentially overlapping publications on submission for editor assessment and evaluation. We submit manuscripts to plagiarism detection tools in order to detect any duplication, overlapping publication or misconduct, and whenever any of these situations is detected, the Editor should contact the authors ant its institution. If editor detects such situation, authors should expect prompt rejection of the submitted manuscript. If the editor was not aware of the situation previously to acceptance of the manuscript, then it will be retracted in a further edition of the Journal.

Authorship criteria
Only person who directly contributed to the articles intellectual contents should be considered authors, according to the criteria below:
1. Created the initial idea and planned the study or interpreted the final results OR
2. Wrote the manuscript or revised its successive versions AND
3. Approved the final version.
Administrative positions and data collection are not considered criteria for authorship and, when appropriate, should be included in the Acknowledgements session.

Manuscripts preparation

All articles should include:
Title page:
Full title of the article
All authors full names
Each author institutional affiliation (only the main affiliation, i.e. affiliation to the institution where the work was developed).
Author for correspondences complete address (including phone and fax numbers and email).
The Institution to be considered as responsible for sending the article.
The projects funding source.
Running title - An alternative title for the article, containing up to 60 characters with spaces. This title should be displayed in all articles sheet headings.
Cover title - When the articles title has more than 100 characters with spaces, an alternative title should be provided, including up to 100 characters (with spaces) to be displayed in the journals cover.

Portuguese abstract: The Portuguese abstract should have up to 250 words. Abbreviations should be avoided as far as possible. It should be structured with the same chapters as the main text (objective, methods, results and conclusion), and accurately reflect the main text contents. In reviews and case reports, the abstract should not be structured. Comments should have abstracts shorter than 100 words. The Portuguese abstract has only to be provided for manuscripts submitted in this language.
English Abstract: The English abstract has only to be provided for manuscripts submitted in this language. Manuscripts submitted in Portuguese will have their Abstract translated into English by the journal.

Six Portuguese and English terms should be provided defining the papers subject. These should be based on the National Library of Medicines MeSH (Medical Subject Headings), available at

The articles should be submitted in MS Word® file with Times New Roman 12 font, double space, including for tables, legends and references. In all article categories the references should be numerical, superscripted, and sequential.

Original articles
These are articles presenting investigational results. The text should have up to 3.500 words, excluding the title sheet, abstract, tables and references. Articles larger than this should be approved by the Editor. The maximal recommended number of authors is eight. If more authors have to be included, this should be justified, explaining each authors participation. Original articles should have:
Introduction - This section should be written as a non-expert stand point, and clearly provide - and if possible, illustrate - the rational for the research and its objectives. Clinical trial reports should, whenever appropriate, include a literature research abstract, indicating why the study was needed and the aimed study contribution. This section should end with a short statement on the article reported subject.
Methods - This should include the study design, the scenario, type of participants or materials, a clear description of interventions and comparisons, type of analysis used and their statistical power, if appropriate.
Results - The results should be presented in clear and logical sequence. The statistical analysis results should include, when appropriate, the relative and absolute risks or risk reductions, and confidence intervals.
Discussion ­­- All results should be discussed and compared to the relevant literature.
Conclusion - This section should clearly discuss the main research conclusions and provide clear explanation on its relevance.
References - References should be sequential, according to the order of quotation on text, and limited to 40 references. See below the reference rules.

Review articles
A review article is a comprehensive description of certain health care aspects relevant to the journal scope. Should have no more than 4000 words (excluding the title sheet, abstract, tables and references) and up to 50 references. They should be written by acknowledgeable experienced authors, and the authors number should not exceed three, except justification to be submitted to the journal. The reviews may be systematic or narrative. In reviews it is also recommended having a "Methods" section, reporting the evidence sources and the key words used for the literature search. Systematic literature reviews containing appropriate search strategies and results are considered original articles.

Case reports
This section is devoted to publish rare medical reports, describing their aspects, history and management. They should include a non-structured abstract, a brief introduction and literature review, the case description and a short discussion. Case reports should have up to 2000 words, with five authors and 10 references.

These are expert-written opinion articles, to be read by the general medical community. Usually the authors are invited by one of the editors, however unsolicited articles are also welcome, and routinely evaluated for publication. The comment objective should be highlighting an issue, expanding the highlighted subject, and suggesting the sequence. Any statement should be referenced, however it is preferable that the reference list is limited to 15. For readability, the sentences should be short and objective. Use subtitles for dividing the comments section. This should be short, up to 800 to 1000 words, except the abstract and references. The number of authors should not exceed two, unless justified.

Letters to the Editor
RBTI publish comments to any article published in the journal and an authors or editors response is generally pertinent. Rebutter is not allowed. These should have up to 500 words and up to 5 references. The subject RBTIs article should be mention in the text and references. The authors should also submit their complete identification and address (including phone number and email). All letters are edited and sent back to the authors before publication.

The journal regularly publishes guidelines and recommendations drawn up by both the Brazilian Association of Intensive Care Medicine (AMIB) and the Portuguese Society of Intensive Care (SPCI).

The authors should use this section to acknowledge eventual research funding and academic organisms support; foment agencies; colleagues and other collaborators. The authors should grant permission from all mentioned in the acknowledgments section. This should be concise, not exceeding 4 lines.

References should be updated, preferably containing the most relevant articles published on the subject in the last five years. They should not contain articles not quoted in text or unpublished works. The references should be consecutively numbered in the text quotation sequence, and identified with Arabic numerals. The display should comply with the Vancouver Style format, as in the models below. The journal titles should be abbreviated according to the National Library of Medicine, available at the List of Journal Indexed in Index Medicus, at
For all references, mention up to six authors. In case of more than six authors, mention the first six authors followed by the expression et al.

Printed articles
Dellinger RP, Vincent JL, Silva E, Townsend S, Bion J, Levy MM. Surviving sepsis in developing countries. Crit Care Med. 2008;36(8):2487-8.

Levy MM, Vincent JL, Jaeschke R, Parker MM, Rivers E, Beale R, et al. Surviving Sepsis Campaign: Guideline Clarification. Crit Care Med. 2008;36(8):2490-1.

Electronic Articles
Buerke M, Prondzinsky R. Levosimendan in cardiogenic shock: better than enoximone! Crit Care Med [Internet]. 2008 [cited 2008 Aug 23];36(8):2450-1. Available from:

Hecksher CA, Lacerda HR, Maciel MA. Características e evolução dos pacientes tratados com drotrecogina alfa e outras intervenções da campanha "Sobrevivendo à Sepse" na prática clínica. Rev Bras Ter Intensiva [Internet]. 2008[citado 2008 Ago 23; 20(2): 135-43. Available at:

Walker LK. Use of extracorporeal membrane oxygenation for preoperative stabilization of congenital diaphragmatic hernia. Crit Care Med. 1993;21 (Supp. l):S379-S380.

Doyle AC. Biological mysteries solved. 2nd ed. London: Science Press; 1991.

Book chapters
Lachmann B, van Daal GJ. Adult respiratory distress syndrome: animal models. In: Robertson B, van Golde LM. Pulmonary surfactant. 2nd ed. Amsterdam: Elsevier; 1992. p. 635-66.

Published abstracts
Varvinski AM, Findlay GP. Immediate complications of central venous cannulation in ICU [abstract]. Crit Care. 2000;4(Suppl 1):P6.

In press articles
Giannini A. Visiting policies and family presence in ICU: a matter for legislation? Intensive Care Med. In press 2012.

Tables and figures
All figures and tables should be numbered according to the order mentioned in the text. Tables and figures should be inserted below the text, following references, only one in each page, the later preferably prepared as MS Excel®, TIF, or JPG with 300 DPI files. Figures needing increased resolution should be submitted in files apart. Figures containing texts should be provided in open files, for translation. If not possible, the author should provide the translation.
The quantities, units and symbols used should adhere to national rules. The figures should have legends explaining the results, allowing understanding without consulting the text. The tables and figures legends should be concise but self-explaining, allowing understanding without consulting the text. The units should be inside the table and statistical tests indicated in the legend.
Surgery and biopsy pictures with special staining techniques will be considered for color printing, being the additional costs the authors responsibility. Figures already published should be accompanied by the author/editor authorization.
Reproduced figures, charts, plots or tables, not originally belonging to the article, should reference the original source.

Abbreviations and initials
The use of abbreviations should be avoided in the articles title, abstract and tables and figures headings. Their use should be minimized in the entire text. They should be preceded by the entire name when first mentioned in the text. The abbreviations, symbols and other signs meanings should be provided in the figures and tables foot notes.

Sending the manuscript
The articles should be electronically submitted at:

Submission On-line

Indexed in




Associação de Medicina Intensiva Brasileira - AMIB

Rua Arminda nº 93 - 7º andar - Vila Olímpia - São Paulo, SP, Brasil - Tel./Fax: (55 11) 5089-2642 | e-mail: [email protected]

Cookie Policy

GN1 - Systems and Publications